Cannabis Stocks

Is GTI Stock the Best MSO for Cannabis Investors?

Contradictions are rife in the societies that surround us. America is one of two countries in the world where pharmaceutical companies can peddle drugs directly to consumers, but if you smoke a plant that grows like a weed, you’ll get put in the slammer in some states. So why has it taken so long for […]

A Yearly Checkup with Trulieve Stock

A large brokerage firm once audited their retail investor accounts to see what characteristics could be attributed to high returns. Turns out that patience is not only a virtue, but a great way to generate alpha. The highest-performing accounts belonged to people who forgot about them or had died. Rome wasn’t built in a day, […]

It’s Finally Time to Invest in Cannabis

Few investment themes have attracted more interest from newbie investors than cannabis. (No, we’ve never considered crypto in its current form to be much of an investment.) Along with strong retail investor interest comes extreme volatility reminiscent of meme stocks. Institutional investors can’t participate and provide stability because many don’t want to get involved with […]

Tilray: Cannabis Stock or Conglomerate?

The more popular an investment theme becomes, the more likely retail investors get burned. Hype around any particular thesis is often driven by niche pundits who spout every bullish point they can dream up in newsletters that double as promotion platforms. That’s why we only invest in a thesis after heavily scrutinizing the space, and […]

Forecasting Growth for GrowGeneration Stock

Oftentimes we’ll come across an investment thesis that crosses multiple disruptive trends. One example would be LiDAR, a technology used in robotics, industrial machinery, smart infrastructure, and autonomous vehicles. Another example is machine vision which is used for a similar swath of use cases. Then we have the indoor growing thesis which lends itself to […]

Focusing on Vertical Integration in the Cannabis Industry

If we had to pick the most complex investment themes we cover, synthetic biology and gene editing would be at the top. So would cannabis. Legalizing marijuana for adult use in various states while keeping things illegal at the federal level has created a very complex environment to navigate. As with any thesis, our goal […]

Cresco Labs Stock: An Impaired Acquisition

For a drug that’s illegal at the federal level, cannabis sure has built a strong brand for itself. Nearly half of all Americans polled by Gallup said they’ve tried cannabis. That’s up from 38% in 2013. One wonders if the uptake is more attributable to changing attitudes towards something Americans declared war on in the […]

Verano Holdings Stock: Growing Like Mad

If you think you’ll day trade your way into a better zip code, think again. Thousands of hedge funds across the globe employ millions of sneaky little AI algorithms that monitor the world’s big data. All that data exhaust being generated by alternative data providers is ingested to provide signals for trading strategies that generate […]

GTI Stock vs Curaleaf Stock: And the Winner Is?

The Johari Window model is a psychological framework used to help people better understand how other people perceive them. You may think you know yourself, but you probably don’t. That’s your true self, and most people don’t really know their true selves. Maybe other people see that true self, or maybe you put on a […]

Trulieve Stock: The Good, The Bad, and The Ugly

We don’t just cover cannabis because we consume loads of the stuff in all forms. Our first piece on the topic – No to Marijuana Stocks, Yes to Weed Investing – was published in 2016 to warn investors about all the over-the-counter (OTC) junk stocks attaching themselves to the cannabis thesis like leeches. Our attempt […]